Copeptin and Arterial Hypotension in Critically Ill Paediatric and Neonatal Intensive Care Patients (COPNIC)

Vincenzo Cannizzaro

Status: Completed

Conditions: Arterial Hypotension in Critically Ill Neonatal and Pediatric Patients

Treatments: Diagnostic Test: Copeptin in plasma

Study type: Observational

Funder types: Other

Identifiers

NCT03320967

KISPI-COPNIC

Details and patient eligibility

About

Blood copeptin will be measured during the routine treatment of neonates, children and adolescents on the Intensive Care Unit of the University Children's Hospital Zurich at different time points (admission, 12, 24, 48, 96, 168 hours after admission). These values will be primarily analysed for their variability and their association with arterial hypotension. Blood samples will be drawn together with otherwise medically indicated blood withdrawals to avoid extra harm. Further, copeptin values will be compared to clinical and vital parameters, all of them open-label available during clinical routine. Copeptin's predictive value for patients' outcome will be analysed as secondary outcome.

Enrollment: 170 patients

Sex: All

Ages: Under 17 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age: first day of life until 18th birthday.
• Ability of the care taker or the adolescent (if≥14 years of age) to understand verbal and written instructions and informed consent in German.

Exclusion criteria

• Care taker or adolescent (if ≥14 years of age) unwilling to give written informed consent.
• Care taker or adolescent (if ≥14 years of age) not understanding German and without a family member able to translate.
• Adolescent (if ≥14 years of age) unwilling to give written informed consent following sedation < 24 hours.
• Care takers of long-term sedated (>24 hours) adolescents (if ≥14 years of age) unwilling to give written informed consent or not present within 24 hours.

Trial design